Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Powles

Showing results (131-140 of 275) with videos related to

Pageof 28
Sort By:
Breast Cancer Research and Treatment|May 19, 2000
Prognostic relevance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapyR K Gregory, T J Powles, J Salter, et al.
The Canadian Journal of Oncology|December 1, 1995
Role of bisphosphonates in prevention and treatment of bone metastases from breast cancerA H Paterson, J A Kanis, T J Powles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancerA H Paterson, T J Powles, J A Kanis, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|July 27, 2007
Screening patients with sensorineural hearing loss for vestibular schwannoma using a Bayesian classifierS A R Nouraei, Q J M Huys, P Chatrath, et al.
Clinical Oncology|March 1, 1982
Weight loss during therapy for advanced breast cancerC M Rowland-Payne, M Abbott, J M Jones, et al.
British Journal of Cancer|August 1, 1991
A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancerT J Powles, A L Jones, I R Judson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndromeA Montes, T J Powles, M E O'Brien, et al.
Clinical Oncology|March 1, 1976
A comparision of grey-scale ultrasound with other methods for the detection of liver metastases from breast carcinomaI E Smith, K J Taylor, V R McCready, et al.
Bulletin Du Cancer|January 1, 1993
[Double-blind trial of oral clodronate in breast cancer patients with bone metastases]A H Paterson, T J Powles, J A Kanis, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Mitomycin C, melphalan and methotrexate combination chemotherapy for palliation of disseminated breast cancerD J Perez, T J Powles, J C Gazet, et al.
Pageof 28

Showing results (131-140 of 275) with videos related to

Sort By:
Pageof 28
Breast Cancer Research and Treatment|May 19, 2000
Prognostic relevance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapyR K Gregory, T J Powles, J Salter, et al.
The Canadian Journal of Oncology|December 1, 1995
Role of bisphosphonates in prevention and treatment of bone metastases from breast cancerA H Paterson, J A Kanis, T J Powles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancerA H Paterson, T J Powles, J A Kanis, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|July 27, 2007
Screening patients with sensorineural hearing loss for vestibular schwannoma using a Bayesian classifierS A R Nouraei, Q J M Huys, P Chatrath, et al.
Clinical Oncology|March 1, 1982
Weight loss during therapy for advanced breast cancerC M Rowland-Payne, M Abbott, J M Jones, et al.
British Journal of Cancer|August 1, 1991
A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancerT J Powles, A L Jones, I R Judson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndromeA Montes, T J Powles, M E O'Brien, et al.
Clinical Oncology|March 1, 1976
A comparision of grey-scale ultrasound with other methods for the detection of liver metastases from breast carcinomaI E Smith, K J Taylor, V R McCready, et al.
Bulletin Du Cancer|January 1, 1993
[Double-blind trial of oral clodronate in breast cancer patients with bone metastases]A H Paterson, T J Powles, J A Kanis, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Mitomycin C, melphalan and methotrexate combination chemotherapy for palliation of disseminated breast cancerD J Perez, T J Powles, J C Gazet, et al.
Pageof 28